Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants

Clinical trial NCT01262872 · COMPLETED

Trial details

NCT number: NCT01262872
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Infections, Streptococcal

Start date: 2011-02-09
Primary completion: 2013-03-18
Enrollment: 1320

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.